Scientists probe deep into body to see how ebola vaccine builds Long-Term shields
NCT ID NCT06100913
Summary
This study aims to understand how long a single dose of the approved Ebola vaccine provides immune protection. Thirty healthy adult volunteers will receive the vaccine and provide blood, lymph node, and bone marrow samples over a year. Researchers will track how the body's immune cells in these different areas respond and create lasting memory against the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBOLA VIRUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Hope Clinic of the Emory Vaccine Center
Decatur, Georgia, 30030, United States
-
Washington University in St. Louis
St Louis, Missouri, 63130, United States
Conditions
Explore the condition pages connected to this study.